Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
33,560
archived clinical trials in
Neurology

Clinical Outcome Study for Dysferlinopathy
International Clinical Outcome Study for Dysferlinopathy
Status: Enrolling
Updated:  3/29/2017
Neurology & Pathology,Washington University School of Medicine in St Louis
mi
from
Saint Louis, MO
Clinical Outcome Study for Dysferlinopathy
International Clinical Outcome Study for Dysferlinopathy
Status: Enrolling
Updated: 3/29/2017
Neurology & Pathology,Washington University School of Medicine in St Louis
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Clinical Outcome Study for Dysferlinopathy
International Clinical Outcome Study for Dysferlinopathy
Status: Enrolling
Updated:  3/29/2017
Carolinas Medical Center, Neuroscience & Spine Institute, Dept of Neurology
mi
from
Charlotte, NC
Clinical Outcome Study for Dysferlinopathy
International Clinical Outcome Study for Dysferlinopathy
Status: Enrolling
Updated: 3/29/2017
Carolinas Medical Center, Neuroscience & Spine Institute, Dept of Neurology
mi
from
Charlotte, NC
Click here to add this to my saved trials
Clinical Outcome Study for Dysferlinopathy
International Clinical Outcome Study for Dysferlinopathy
Status: Enrolling
Updated:  3/29/2017
Neuromuscular Center at the Research Institute of Nationwide Childrens Hospital
mi
from
Columbus, OH
Clinical Outcome Study for Dysferlinopathy
International Clinical Outcome Study for Dysferlinopathy
Status: Enrolling
Updated: 3/29/2017
Neuromuscular Center at the Research Institute of Nationwide Childrens Hospital
mi
from
Columbus, OH
Click here to add this to my saved trials
Clinical Outcome Study for Dysferlinopathy
International Clinical Outcome Study for Dysferlinopathy
Status: Enrolling
Updated:  3/29/2017
Stanford University Medical Center
mi
from
Palo Alto, CA
Clinical Outcome Study for Dysferlinopathy
International Clinical Outcome Study for Dysferlinopathy
Status: Enrolling
Updated: 3/29/2017
Stanford University Medical Center
mi
from
Palo Alto, CA
Click here to add this to my saved trials
Clinical Outcome Study for Dysferlinopathy
International Clinical Outcome Study for Dysferlinopathy
Status: Enrolling
Updated:  3/29/2017
The Children's Hospital at Westmead, Institute for Neuroscience and Muscle Research
mi
from
Westmead, Sydney,
Clinical Outcome Study for Dysferlinopathy
International Clinical Outcome Study for Dysferlinopathy
Status: Enrolling
Updated: 3/29/2017
The Children's Hospital at Westmead, Institute for Neuroscience and Muscle Research
mi
from
Westmead, Sydney,
Click here to add this to my saved trials
Mazindol Controlled Release in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
A Double-Blind Placebo-Controlled Phase II Study to Determine the Efficacy, Safety, Tolerability and Pharmacokinetics of a Controlled Release (CR) Formulation of Mazindol in Adults With DSM-5 Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  3/30/2017
AVIDA Clinic
mi
from
Newport Beach, CA
Mazindol Controlled Release in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
A Double-Blind Placebo-Controlled Phase II Study to Determine the Efficacy, Safety, Tolerability and Pharmacokinetics of a Controlled Release (CR) Formulation of Mazindol in Adults With DSM-5 Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 3/30/2017
AVIDA Clinic
mi
from
Newport Beach, CA
Click here to add this to my saved trials
Mazindol Controlled Release in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
A Double-Blind Placebo-Controlled Phase II Study to Determine the Efficacy, Safety, Tolerability and Pharmacokinetics of a Controlled Release (CR) Formulation of Mazindol in Adults With DSM-5 Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  3/30/2017
CNS Healthcare, Inc
mi
from
Jacksonville, FL
Mazindol Controlled Release in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
A Double-Blind Placebo-Controlled Phase II Study to Determine the Efficacy, Safety, Tolerability and Pharmacokinetics of a Controlled Release (CR) Formulation of Mazindol in Adults With DSM-5 Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 3/30/2017
CNS Healthcare, Inc
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Mazindol Controlled Release in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
A Double-Blind Placebo-Controlled Phase II Study to Determine the Efficacy, Safety, Tolerability and Pharmacokinetics of a Controlled Release (CR) Formulation of Mazindol in Adults With DSM-5 Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  3/30/2017
South Shore Psychiatric Services, PC
mi
from
Marshfield, MA
Mazindol Controlled Release in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
A Double-Blind Placebo-Controlled Phase II Study to Determine the Efficacy, Safety, Tolerability and Pharmacokinetics of a Controlled Release (CR) Formulation of Mazindol in Adults With DSM-5 Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 3/30/2017
South Shore Psychiatric Services, PC
mi
from
Marshfield, MA
Click here to add this to my saved trials
Mazindol Controlled Release in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
A Double-Blind Placebo-Controlled Phase II Study to Determine the Efficacy, Safety, Tolerability and Pharmacokinetics of a Controlled Release (CR) Formulation of Mazindol in Adults With DSM-5 Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  3/30/2017
Rochester Center for Behavorial Medicine
mi
from
Rochester Hills, MI
Mazindol Controlled Release in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
A Double-Blind Placebo-Controlled Phase II Study to Determine the Efficacy, Safety, Tolerability and Pharmacokinetics of a Controlled Release (CR) Formulation of Mazindol in Adults With DSM-5 Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 3/30/2017
Rochester Center for Behavorial Medicine
mi
from
Rochester Hills, MI
Click here to add this to my saved trials
Mazindol Controlled Release in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
A Double-Blind Placebo-Controlled Phase II Study to Determine the Efficacy, Safety, Tolerability and Pharmacokinetics of a Controlled Release (CR) Formulation of Mazindol in Adults With DSM-5 Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  3/30/2017
Midwest Research Group at St. Charles Psychiatric Associates
mi
from
St. Charles, MO
Mazindol Controlled Release in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
A Double-Blind Placebo-Controlled Phase II Study to Determine the Efficacy, Safety, Tolerability and Pharmacokinetics of a Controlled Release (CR) Formulation of Mazindol in Adults With DSM-5 Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 3/30/2017
Midwest Research Group at St. Charles Psychiatric Associates
mi
from
St. Charles, MO
Click here to add this to my saved trials
Mazindol Controlled Release in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
A Double-Blind Placebo-Controlled Phase II Study to Determine the Efficacy, Safety, Tolerability and Pharmacokinetics of a Controlled Release (CR) Formulation of Mazindol in Adults With DSM-5 Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  3/30/2017
Clinical NeuroScience Solutions, Inc.
mi
from
Memphis, TN
Mazindol Controlled Release in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
A Double-Blind Placebo-Controlled Phase II Study to Determine the Efficacy, Safety, Tolerability and Pharmacokinetics of a Controlled Release (CR) Formulation of Mazindol in Adults With DSM-5 Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 3/30/2017
Clinical NeuroScience Solutions, Inc.
mi
from
Memphis, TN
Click here to add this to my saved trials
Mazindol Controlled Release in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
A Double-Blind Placebo-Controlled Phase II Study to Determine the Efficacy, Safety, Tolerability and Pharmacokinetics of a Controlled Release (CR) Formulation of Mazindol in Adults With DSM-5 Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  3/30/2017
Memorial Park Psychiatry / Bayou City Research
mi
from
Houston, TX
Mazindol Controlled Release in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
A Double-Blind Placebo-Controlled Phase II Study to Determine the Efficacy, Safety, Tolerability and Pharmacokinetics of a Controlled Release (CR) Formulation of Mazindol in Adults With DSM-5 Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 3/30/2017
Memorial Park Psychiatry / Bayou City Research
mi
from
Houston, TX
Click here to add this to my saved trials
Visual Feedback Therapy for Treating Individuals With Hemiparesis Following Stroke
Visual Feedback Therapy for Treating Individuals With Hemiparesis Following Stroke
Status: Enrolling
Updated:  4/3/2017
Einstein Medical Center Elkins Park
mi
from
Elkins Park, PA
Visual Feedback Therapy for Treating Individuals With Hemiparesis Following Stroke
Visual Feedback Therapy for Treating Individuals With Hemiparesis Following Stroke
Status: Enrolling
Updated: 4/3/2017
Einstein Medical Center Elkins Park
mi
from
Elkins Park, PA
Click here to add this to my saved trials
Bone Graft Materials Observational Registry
A Prospective Patient Registry for Bone Graft Substitutes in Spinal Fusion: Patient Outcomes and Use in Clinical Practice
Status: Enrolling
Updated:  4/4/2017
St. Joseph's Hospital - Resurgeons Orthopedics
mi
from
Atlanta, GA
Bone Graft Materials Observational Registry
A Prospective Patient Registry for Bone Graft Substitutes in Spinal Fusion: Patient Outcomes and Use in Clinical Practice
Status: Enrolling
Updated: 4/4/2017
St. Joseph's Hospital - Resurgeons Orthopedics
mi
from
Atlanta, GA
Click here to add this to my saved trials
Bone Graft Materials Observational Registry
A Prospective Patient Registry for Bone Graft Substitutes in Spinal Fusion: Patient Outcomes and Use in Clinical Practice
Status: Enrolling
Updated:  4/4/2017
Arthritis & Joint Center - U. Mass. Memorial
mi
from
Worcester, MA
Bone Graft Materials Observational Registry
A Prospective Patient Registry for Bone Graft Substitutes in Spinal Fusion: Patient Outcomes and Use in Clinical Practice
Status: Enrolling
Updated: 4/4/2017
Arthritis & Joint Center - U. Mass. Memorial
mi
from
Worcester, MA
Click here to add this to my saved trials
Bone Graft Materials Observational Registry
A Prospective Patient Registry for Bone Graft Substitutes in Spinal Fusion: Patient Outcomes and Use in Clinical Practice
Status: Enrolling
Updated:  4/4/2017
PRESSD
mi
from
Southfield, MI
Bone Graft Materials Observational Registry
A Prospective Patient Registry for Bone Graft Substitutes in Spinal Fusion: Patient Outcomes and Use in Clinical Practice
Status: Enrolling
Updated: 4/4/2017
PRESSD
mi
from
Southfield, MI
Click here to add this to my saved trials
Bone Graft Materials Observational Registry
A Prospective Patient Registry for Bone Graft Substitutes in Spinal Fusion: Patient Outcomes and Use in Clinical Practice
Status: Enrolling
Updated:  4/4/2017
Montana Neuroscience Institute Foundation
mi
from
Missoula, MT
Bone Graft Materials Observational Registry
A Prospective Patient Registry for Bone Graft Substitutes in Spinal Fusion: Patient Outcomes and Use in Clinical Practice
Status: Enrolling
Updated: 4/4/2017
Montana Neuroscience Institute Foundation
mi
from
Missoula, MT
Click here to add this to my saved trials
Bone Graft Materials Observational Registry
A Prospective Patient Registry for Bone Graft Substitutes in Spinal Fusion: Patient Outcomes and Use in Clinical Practice
Status: Enrolling
Updated:  4/4/2017
Syracuse Orthopedic Specialists
mi
from
Syracuse, NY
Bone Graft Materials Observational Registry
A Prospective Patient Registry for Bone Graft Substitutes in Spinal Fusion: Patient Outcomes and Use in Clinical Practice
Status: Enrolling
Updated: 4/4/2017
Syracuse Orthopedic Specialists
mi
from
Syracuse, NY
Click here to add this to my saved trials
Bone Graft Materials Observational Registry
A Prospective Patient Registry for Bone Graft Substitutes in Spinal Fusion: Patient Outcomes and Use in Clinical Practice
Status: Enrolling
Updated:  4/4/2017
Neurosurgical Associates
mi
from
Nashville, TN
Bone Graft Materials Observational Registry
A Prospective Patient Registry for Bone Graft Substitutes in Spinal Fusion: Patient Outcomes and Use in Clinical Practice
Status: Enrolling
Updated: 4/4/2017
Neurosurgical Associates
mi
from
Nashville, TN
Click here to add this to my saved trials
Bone Graft Materials Observational Registry
A Prospective Patient Registry for Bone Graft Substitutes in Spinal Fusion: Patient Outcomes and Use in Clinical Practice
Status: Enrolling
Updated:  4/4/2017
Brain & Spine of Texas
mi
from
Plano, TX
Bone Graft Materials Observational Registry
A Prospective Patient Registry for Bone Graft Substitutes in Spinal Fusion: Patient Outcomes and Use in Clinical Practice
Status: Enrolling
Updated: 4/4/2017
Brain & Spine of Texas
mi
from
Plano, TX
Click here to add this to my saved trials
Bone Graft Materials Observational Registry
A Prospective Patient Registry for Bone Graft Substitutes in Spinal Fusion: Patient Outcomes and Use in Clinical Practice
Status: Enrolling
Updated:  4/4/2017
UCSF
mi
from
San Francisco, CA
Bone Graft Materials Observational Registry
A Prospective Patient Registry for Bone Graft Substitutes in Spinal Fusion: Patient Outcomes and Use in Clinical Practice
Status: Enrolling
Updated: 4/4/2017
UCSF
mi
from
San Francisco, CA
Click here to add this to my saved trials
Bone Graft Materials Observational Registry
A Prospective Patient Registry for Bone Graft Substitutes in Spinal Fusion: Patient Outcomes and Use in Clinical Practice
Status: Enrolling
Updated:  4/4/2017
Carrollton Orthopedics
mi
from
Carrollton, GA
Bone Graft Materials Observational Registry
A Prospective Patient Registry for Bone Graft Substitutes in Spinal Fusion: Patient Outcomes and Use in Clinical Practice
Status: Enrolling
Updated: 4/4/2017
Carrollton Orthopedics
mi
from
Carrollton, GA
Click here to add this to my saved trials
Bone Graft Materials Observational Registry
A Prospective Patient Registry for Bone Graft Substitutes in Spinal Fusion: Patient Outcomes and Use in Clinical Practice
Status: Enrolling
Updated:  4/4/2017
Bluegrass Orthopedics & Hand Care Research
mi
from
Lexington, KY
Bone Graft Materials Observational Registry
A Prospective Patient Registry for Bone Graft Substitutes in Spinal Fusion: Patient Outcomes and Use in Clinical Practice
Status: Enrolling
Updated: 4/4/2017
Bluegrass Orthopedics & Hand Care Research
mi
from
Lexington, KY
Click here to add this to my saved trials
Bone Graft Materials Observational Registry
A Prospective Patient Registry for Bone Graft Substitutes in Spinal Fusion: Patient Outcomes and Use in Clinical Practice
Status: Enrolling
Updated:  4/4/2017
Henry Ford West Bloomfield Hospital
mi
from
West Bloomfield, MI
Bone Graft Materials Observational Registry
A Prospective Patient Registry for Bone Graft Substitutes in Spinal Fusion: Patient Outcomes and Use in Clinical Practice
Status: Enrolling
Updated: 4/4/2017
Henry Ford West Bloomfield Hospital
mi
from
West Bloomfield, MI
Click here to add this to my saved trials
Bone Graft Materials Observational Registry
A Prospective Patient Registry for Bone Graft Substitutes in Spinal Fusion: Patient Outcomes and Use in Clinical Practice
Status: Enrolling
Updated:  4/4/2017
Physicians Research Options Spine Center
mi
from
Las Vegas, NV
Bone Graft Materials Observational Registry
A Prospective Patient Registry for Bone Graft Substitutes in Spinal Fusion: Patient Outcomes and Use in Clinical Practice
Status: Enrolling
Updated: 4/4/2017
Physicians Research Options Spine Center
mi
from
Las Vegas, NV
Click here to add this to my saved trials
Bone Graft Materials Observational Registry
A Prospective Patient Registry for Bone Graft Substitutes in Spinal Fusion: Patient Outcomes and Use in Clinical Practice
Status: Enrolling
Updated:  4/4/2017
Buda Health Center
mi
from
Budapest,
Bone Graft Materials Observational Registry
A Prospective Patient Registry for Bone Graft Substitutes in Spinal Fusion: Patient Outcomes and Use in Clinical Practice
Status: Enrolling
Updated: 4/4/2017
Buda Health Center
mi
from
Budapest,
Click here to add this to my saved trials
Ecopipam Treatment of Tourette's Syndrome in Subjects 7-17 Years
Ecopipam Treatment of Tourette's Syndrome in Subjects 7-17 Years
Status: Enrolling
Updated:  4/4/2017
University of South Florida - Rothman Center for Neuropsychiatry
mi
from
St. Petersburg, FL
Ecopipam Treatment of Tourette's Syndrome in Subjects 7-17 Years
Ecopipam Treatment of Tourette's Syndrome in Subjects 7-17 Years
Status: Enrolling
Updated: 4/4/2017
University of South Florida - Rothman Center for Neuropsychiatry
mi
from
St. Petersburg, FL
Click here to add this to my saved trials
Ecopipam Treatment of Tourette's Syndrome in Subjects 7-17 Years
Ecopipam Treatment of Tourette's Syndrome in Subjects 7-17 Years
Status: Enrolling
Updated:  4/4/2017
Emory University School of Medicine
mi
from
Atlanta, GA
Ecopipam Treatment of Tourette's Syndrome in Subjects 7-17 Years
Ecopipam Treatment of Tourette's Syndrome in Subjects 7-17 Years
Status: Enrolling
Updated: 4/4/2017
Emory University School of Medicine
mi
from
Atlanta, GA
Click here to add this to my saved trials
Ecopipam Treatment of Tourette's Syndrome in Subjects 7-17 Years
Ecopipam Treatment of Tourette's Syndrome in Subjects 7-17 Years
Status: Enrolling
Updated:  4/4/2017
University of Chicago Medical School
mi
from
Chicago, IL
Ecopipam Treatment of Tourette's Syndrome in Subjects 7-17 Years
Ecopipam Treatment of Tourette's Syndrome in Subjects 7-17 Years
Status: Enrolling
Updated: 4/4/2017
University of Chicago Medical School
mi
from
Chicago, IL
Click here to add this to my saved trials
Ecopipam Treatment of Tourette's Syndrome in Subjects 7-17 Years
Ecopipam Treatment of Tourette's Syndrome in Subjects 7-17 Years
Status: Enrolling
Updated:  4/4/2017
Children's Mercy Kansas City
mi
from
Kansas City, KA
Ecopipam Treatment of Tourette's Syndrome in Subjects 7-17 Years
Ecopipam Treatment of Tourette's Syndrome in Subjects 7-17 Years
Status: Enrolling
Updated: 4/4/2017
Children's Mercy Kansas City
mi
from
Kansas City, KA
Click here to add this to my saved trials
Ecopipam Treatment of Tourette's Syndrome in Subjects 7-17 Years
Ecopipam Treatment of Tourette's Syndrome in Subjects 7-17 Years
Status: Enrolling
Updated:  4/4/2017
Washington University School of Medicine
mi
from
St. Louis, MO
Ecopipam Treatment of Tourette's Syndrome in Subjects 7-17 Years
Ecopipam Treatment of Tourette's Syndrome in Subjects 7-17 Years
Status: Enrolling
Updated: 4/4/2017
Washington University School of Medicine
mi
from
St. Louis, MO
Click here to add this to my saved trials
Ecopipam Treatment of Tourette's Syndrome in Subjects 7-17 Years
Ecopipam Treatment of Tourette's Syndrome in Subjects 7-17 Years
Status: Enrolling
Updated:  4/4/2017
Overlook Hospital
mi
from
Summit, NJ
Ecopipam Treatment of Tourette's Syndrome in Subjects 7-17 Years
Ecopipam Treatment of Tourette's Syndrome in Subjects 7-17 Years
Status: Enrolling
Updated: 4/4/2017
Overlook Hospital
mi
from
Summit, NJ
Click here to add this to my saved trials
Ecopipam Treatment of Tourette's Syndrome in Subjects 7-17 Years
Ecopipam Treatment of Tourette's Syndrome in Subjects 7-17 Years
Status: Enrolling
Updated:  4/4/2017
North Shore-Long Island Jewish Hosptial
mi
from
Manhasset, NY
Ecopipam Treatment of Tourette's Syndrome in Subjects 7-17 Years
Ecopipam Treatment of Tourette's Syndrome in Subjects 7-17 Years
Status: Enrolling
Updated: 4/4/2017
North Shore-Long Island Jewish Hosptial
mi
from
Manhasset, NY
Click here to add this to my saved trials
Ecopipam Treatment of Tourette's Syndrome in Subjects 7-17 Years
Ecopipam Treatment of Tourette's Syndrome in Subjects 7-17 Years
Status: Enrolling
Updated:  4/4/2017
Weill Cornell Medical School
mi
from
New York City, NY
Ecopipam Treatment of Tourette's Syndrome in Subjects 7-17 Years
Ecopipam Treatment of Tourette's Syndrome in Subjects 7-17 Years
Status: Enrolling
Updated: 4/4/2017
Weill Cornell Medical School
mi
from
New York City, NY
Click here to add this to my saved trials
Ecopipam Treatment of Tourette's Syndrome in Subjects 7-17 Years
Ecopipam Treatment of Tourette's Syndrome in Subjects 7-17 Years
Status: Enrolling
Updated:  4/4/2017
Cincinnati Children's Hospital
mi
from
Cincinnati, OH
Ecopipam Treatment of Tourette's Syndrome in Subjects 7-17 Years
Ecopipam Treatment of Tourette's Syndrome in Subjects 7-17 Years
Status: Enrolling
Updated: 4/4/2017
Cincinnati Children's Hospital
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Ecopipam Treatment of Tourette's Syndrome in Subjects 7-17 Years
Ecopipam Treatment of Tourette's Syndrome in Subjects 7-17 Years
Status: Enrolling
Updated:  4/4/2017
Baylor College of Medicine
mi
from
Houston, TX
Ecopipam Treatment of Tourette's Syndrome in Subjects 7-17 Years
Ecopipam Treatment of Tourette's Syndrome in Subjects 7-17 Years
Status: Enrolling
Updated: 4/4/2017
Baylor College of Medicine
mi
from
Houston, TX
Click here to add this to my saved trials
Ecopipam Treatment of Tourette's Syndrome in Subjects 7-17 Years
Ecopipam Treatment of Tourette's Syndrome in Subjects 7-17 Years
Status: Enrolling
Updated:  4/4/2017
UCLA
mi
from
Los Angeles, CA
Ecopipam Treatment of Tourette's Syndrome in Subjects 7-17 Years
Ecopipam Treatment of Tourette's Syndrome in Subjects 7-17 Years
Status: Enrolling
Updated: 4/4/2017
UCLA
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Noninvasive Neuromodulation for Treatment of Symptoms Due to Mild or Moderate Traumatic Brain Injury
Cranial Nerve Noninvasive Neuromodulation Using the PoNS for Treatment of Symptoms Due to Mild or Moderate Traumatic Brain Injury
Status: Enrolling
Updated:  4/4/2017
TCNL, Department of Kinesiology, UW Madison
mi
from
Madison, WI
Noninvasive Neuromodulation for Treatment of Symptoms Due to Mild or Moderate Traumatic Brain Injury
Cranial Nerve Noninvasive Neuromodulation Using the PoNS for Treatment of Symptoms Due to Mild or Moderate Traumatic Brain Injury
Status: Enrolling
Updated: 4/4/2017
TCNL, Department of Kinesiology, UW Madison
mi
from
Madison, WI
Click here to add this to my saved trials
Efficacy of Albumin Dialysis to Treat Patients With Hepatic Encephalopathy Using The Molecular Adsorbent Recirculating System (MARS)
A Prospective, Controlled Study Of The Clinical Efficacy Of Albumin Dialysis Using The Molecular Adsorbent Recirculating System (MARS®) For The Treatment Of Patients With Hepatic Encephalopathy
Status: Enrolling
Updated:  4/4/2017
University of Alabama
mi
from
Birmingham, AL
Efficacy of Albumin Dialysis to Treat Patients With Hepatic Encephalopathy Using The Molecular Adsorbent Recirculating System (MARS)
A Prospective, Controlled Study Of The Clinical Efficacy Of Albumin Dialysis Using The Molecular Adsorbent Recirculating System (MARS®) For The Treatment Of Patients With Hepatic Encephalopathy
Status: Enrolling
Updated: 4/4/2017
University of Alabama
mi
from
Birmingham, AL
Click here to add this to my saved trials
Efficacy of Albumin Dialysis to Treat Patients With Hepatic Encephalopathy Using The Molecular Adsorbent Recirculating System (MARS)
A Prospective, Controlled Study Of The Clinical Efficacy Of Albumin Dialysis Using The Molecular Adsorbent Recirculating System (MARS®) For The Treatment Of Patients With Hepatic Encephalopathy
Status: Enrolling
Updated:  4/4/2017
University of California, San Diego
mi
from
San Diego, CA
Efficacy of Albumin Dialysis to Treat Patients With Hepatic Encephalopathy Using The Molecular Adsorbent Recirculating System (MARS)
A Prospective, Controlled Study Of The Clinical Efficacy Of Albumin Dialysis Using The Molecular Adsorbent Recirculating System (MARS®) For The Treatment Of Patients With Hepatic Encephalopathy
Status: Enrolling
Updated: 4/4/2017
University of California, San Diego
mi
from
San Diego, CA
Click here to add this to my saved trials
Efficacy of Albumin Dialysis to Treat Patients With Hepatic Encephalopathy Using The Molecular Adsorbent Recirculating System (MARS)
A Prospective, Controlled Study Of The Clinical Efficacy Of Albumin Dialysis Using The Molecular Adsorbent Recirculating System (MARS®) For The Treatment Of Patients With Hepatic Encephalopathy
Status: Enrolling
Updated:  4/4/2017
Northwestern University
mi
from
Chicago, IL
Efficacy of Albumin Dialysis to Treat Patients With Hepatic Encephalopathy Using The Molecular Adsorbent Recirculating System (MARS)
A Prospective, Controlled Study Of The Clinical Efficacy Of Albumin Dialysis Using The Molecular Adsorbent Recirculating System (MARS®) For The Treatment Of Patients With Hepatic Encephalopathy
Status: Enrolling
Updated: 4/4/2017
Northwestern University
mi
from
Chicago, IL
Click here to add this to my saved trials
Efficacy of Albumin Dialysis to Treat Patients With Hepatic Encephalopathy Using The Molecular Adsorbent Recirculating System (MARS)
A Prospective, Controlled Study Of The Clinical Efficacy Of Albumin Dialysis Using The Molecular Adsorbent Recirculating System (MARS®) For The Treatment Of Patients With Hepatic Encephalopathy
Status: Enrolling
Updated:  4/4/2017
University of Michigan
mi
from
Ann Arbor, MI
Efficacy of Albumin Dialysis to Treat Patients With Hepatic Encephalopathy Using The Molecular Adsorbent Recirculating System (MARS)
A Prospective, Controlled Study Of The Clinical Efficacy Of Albumin Dialysis Using The Molecular Adsorbent Recirculating System (MARS®) For The Treatment Of Patients With Hepatic Encephalopathy
Status: Enrolling
Updated: 4/4/2017
University of Michigan
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Efficacy of Albumin Dialysis to Treat Patients With Hepatic Encephalopathy Using The Molecular Adsorbent Recirculating System (MARS)
A Prospective, Controlled Study Of The Clinical Efficacy Of Albumin Dialysis Using The Molecular Adsorbent Recirculating System (MARS®) For The Treatment Of Patients With Hepatic Encephalopathy
Status: Enrolling
Updated:  4/4/2017
Columbia Presbyterian Med Ctr
mi
from
New York, NY
Efficacy of Albumin Dialysis to Treat Patients With Hepatic Encephalopathy Using The Molecular Adsorbent Recirculating System (MARS)
A Prospective, Controlled Study Of The Clinical Efficacy Of Albumin Dialysis Using The Molecular Adsorbent Recirculating System (MARS®) For The Treatment Of Patients With Hepatic Encephalopathy
Status: Enrolling
Updated: 4/4/2017
Columbia Presbyterian Med Ctr
mi
from
New York, NY
Click here to add this to my saved trials
Efficacy of Albumin Dialysis to Treat Patients With Hepatic Encephalopathy Using The Molecular Adsorbent Recirculating System (MARS)
A Prospective, Controlled Study Of The Clinical Efficacy Of Albumin Dialysis Using The Molecular Adsorbent Recirculating System (MARS®) For The Treatment Of Patients With Hepatic Encephalopathy
Status: Enrolling
Updated:  4/4/2017
University of Virginia
mi
from
Charlottesville, VA
Efficacy of Albumin Dialysis to Treat Patients With Hepatic Encephalopathy Using The Molecular Adsorbent Recirculating System (MARS)
A Prospective, Controlled Study Of The Clinical Efficacy Of Albumin Dialysis Using The Molecular Adsorbent Recirculating System (MARS®) For The Treatment Of Patients With Hepatic Encephalopathy
Status: Enrolling
Updated: 4/4/2017
University of Virginia
mi
from
Charlottesville, VA
Click here to add this to my saved trials
Efficacy of Albumin Dialysis to Treat Patients With Hepatic Encephalopathy Using The Molecular Adsorbent Recirculating System (MARS)
A Prospective, Controlled Study Of The Clinical Efficacy Of Albumin Dialysis Using The Molecular Adsorbent Recirculating System (MARS®) For The Treatment Of Patients With Hepatic Encephalopathy
Status: Enrolling
Updated:  4/4/2017
UZ Gasthuisberg
mi
from
Leuven,
Efficacy of Albumin Dialysis to Treat Patients With Hepatic Encephalopathy Using The Molecular Adsorbent Recirculating System (MARS)
A Prospective, Controlled Study Of The Clinical Efficacy Of Albumin Dialysis Using The Molecular Adsorbent Recirculating System (MARS®) For The Treatment Of Patients With Hepatic Encephalopathy
Status: Enrolling
Updated: 4/4/2017
UZ Gasthuisberg
mi
from
Leuven,
Click here to add this to my saved trials
An Open-label Safety, Tolerability, and Dose-range Finding Study of Nusinersen (ISIS 396443) in Participants With Spinal Muscular Atrophy (SMA)
An Open-label, Escalating Dose Study to Assess the Safety, Tolerability and Dose-range Finding of a Single Intrathecal Dose of ISIS 396443 in Patients With Spinal Muscular Atrophy
Status: Enrolling
Updated:  4/5/2017
Columbia University Medical Center
mi
from
New York, NY
An Open-label Safety, Tolerability, and Dose-range Finding Study of Nusinersen (ISIS 396443) in Participants With Spinal Muscular Atrophy (SMA)
An Open-label, Escalating Dose Study to Assess the Safety, Tolerability and Dose-range Finding of a Single Intrathecal Dose of ISIS 396443 in Patients With Spinal Muscular Atrophy
Status: Enrolling
Updated: 4/5/2017
Columbia University Medical Center
mi
from
New York, NY
Click here to add this to my saved trials
An Open-label Safety, Tolerability, and Dose-range Finding Study of Nusinersen (ISIS 396443) in Participants With Spinal Muscular Atrophy (SMA)
An Open-label, Escalating Dose Study to Assess the Safety, Tolerability and Dose-range Finding of a Single Intrathecal Dose of ISIS 396443 in Patients With Spinal Muscular Atrophy
Status: Enrolling
Updated:  4/5/2017
UT Southwestern Medical Center - Children's Medical Center Dallas
mi
from
Dallas, TX
An Open-label Safety, Tolerability, and Dose-range Finding Study of Nusinersen (ISIS 396443) in Participants With Spinal Muscular Atrophy (SMA)
An Open-label, Escalating Dose Study to Assess the Safety, Tolerability and Dose-range Finding of a Single Intrathecal Dose of ISIS 396443 in Patients With Spinal Muscular Atrophy
Status: Enrolling
Updated: 4/5/2017
UT Southwestern Medical Center - Children's Medical Center Dallas
mi
from
Dallas, TX
Click here to add this to my saved trials
An Open-label Safety, Tolerability, and Dose-range Finding Study of Nusinersen (ISIS 396443) in Participants With Spinal Muscular Atrophy (SMA)
An Open-label, Escalating Dose Study to Assess the Safety, Tolerability and Dose-range Finding of a Single Intrathecal Dose of ISIS 396443 in Patients With Spinal Muscular Atrophy
Status: Enrolling
Updated:  4/5/2017
University of Utah School of Medicine
mi
from
Salt Lake City, UT
An Open-label Safety, Tolerability, and Dose-range Finding Study of Nusinersen (ISIS 396443) in Participants With Spinal Muscular Atrophy (SMA)
An Open-label, Escalating Dose Study to Assess the Safety, Tolerability and Dose-range Finding of a Single Intrathecal Dose of ISIS 396443 in Patients With Spinal Muscular Atrophy
Status: Enrolling
Updated: 4/5/2017
University of Utah School of Medicine
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
An Open-label Safety, Tolerability, and Dose-range Finding Study of Nusinersen (ISIS 396443) in Participants With Spinal Muscular Atrophy (SMA)
An Open-label, Escalating Dose Study to Assess the Safety, Tolerability and Dose-range Finding of a Single Intrathecal Dose of ISIS 396443 in Patients With Spinal Muscular Atrophy
Status: Enrolling
Updated:  4/5/2017
Children's Hospital Boston
mi
from
Boston, MA
An Open-label Safety, Tolerability, and Dose-range Finding Study of Nusinersen (ISIS 396443) in Participants With Spinal Muscular Atrophy (SMA)
An Open-label, Escalating Dose Study to Assess the Safety, Tolerability and Dose-range Finding of a Single Intrathecal Dose of ISIS 396443 in Patients With Spinal Muscular Atrophy
Status: Enrolling
Updated: 4/5/2017
Children's Hospital Boston
mi
from
Boston, MA
Click here to add this to my saved trials
Study of Pomalidomide (CC-4047) to Evaluate Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Effectiveness for Subjects With Systemic Sclerosis With Interstitial Lung Disease
A Phase 2, Proof-Of-Concept, Multicenter, Randomized, Double-Blind, Placebo- Controlled, Study to Evaluate the Safety, Tolerablity, Pharmacokinetics, Pharmacodynamics and Efficacy of Pomalidomide (CC-4047) in Subjects With Systemic Sclerosis With Interstitial Lung Disease
Status: Enrolling
Updated:  4/5/2017
Advances In Medicine
mi
from
Rancho Mirage, CA
Study of Pomalidomide (CC-4047) to Evaluate Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Effectiveness for Subjects With Systemic Sclerosis With Interstitial Lung Disease
A Phase 2, Proof-Of-Concept, Multicenter, Randomized, Double-Blind, Placebo- Controlled, Study to Evaluate the Safety, Tolerablity, Pharmacokinetics, Pharmacodynamics and Efficacy of Pomalidomide (CC-4047) in Subjects With Systemic Sclerosis With Interstitial Lung Disease
Status: Enrolling
Updated: 4/5/2017
Advances In Medicine
mi
from
Rancho Mirage, CA
Click here to add this to my saved trials